Escientia establishes subsidiary in the Basel Area
The U.S. company Escientia Life Sciences Group has established a subsidiary in the canton of Basel-Landschaft. Escientia Switzerland will offer services to innovators and biotech startups at its Schweizerhalle facility.
Escientia's logo being assembled in Schweizerhalle (img: Escientia)
The new Escientia Switzerland subsidiary of the Escientia Life Sciences Group is based in Schweizerhalle, the industrial complex in the municipalities of Muttenz and Pratteln. The U.S. company offers services in the areas of drug discovery, development, production and commercialization. In the Getec Park in Schweizerhalle, Escientia has newly acquired a plant previously operated by Novartis. The investment and innovation promotion agency Basel Area Business & Innovation as well as the Standortförderung Baselland supported Escientia in establishing the subsidiary (read more about starting a business in Switzerland).
Escientia Switzerland will invest a two-digit million Swiss franc amount to modernize the plant and install manufacturing facilities for drug substance production. The 17,000 square meter site will then be providing services to large innovators and biotech startups in the Basel Area.
Alongside the various life sciences companies in the region that might be potential customers of Escientia, the U.S. company will also benefit from the highly qualified employees that the Basel Area has to offer. For this year alone, the creation of approximately 60 jobs is planned.
Share this article
You may also be interested in
Ground-breaking oncology being developed in the Basel Area
The Basel Area – covering northwestern Switzerland – has seen tremendous growth in recent years, and has become a true...Read More
Genedata expanding its user network
The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site...Read More
How Moderna is growing in Switzerland
The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...Read More
Sandoz decides on Basel for headquarters
Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...Read More
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...Read More
University of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...Read More